1-1 of 1
Authors: Kunihiko Ozaki
Journal Article
Circulating Interleukin 6 and Albumin, and Infliximab Levels Are Good Predictors of Recovering Efficacy After Dose Escalation Infliximab Therapy in Patients with Loss of Response to Treatment for Crohn's Disease: A Prospective Clinical Trial Get access
Inflammatory Bowel Diseases, Volume 21, Issue 9, 1 September 2015, Pages 2114–2122, https://doi.org/10.1097/MIB.0000000000000475
Published: 24 July 2015
